
Johnson & Johnson
JNJ 270.24 (0.00%) 0.00
Health Care
Pharmaceuticals
Quality Checklist 6/8
5Y Shares Out Change < 0%
ROIC > 10%
Debt/Equity < 1
Current Ratio > 1
Net Margin > 10%
Est. EPS Growth > 5%
Quick Ratio > 1
Past Net Income CAGR > 0%
0.0%of Portfolio
My holdings
Day change:
Total change:
Shares:Cost basis:
Market cap: $651.25(B)
EV: $679.53(B)
Total Equity: $84.97(B)
Earnings date: Oct-13-2026
P/E: 30.92
Forward P/E: 24.46
P/FCF: 29.25
P/S: 6.64
P/B: 7.66
EPS: $8.7
EPS (fwd): $11.1
FCF/share: $9.2
Revenue/share: $40.7
Book value/share: $35.3
ROIC: 21.7%
ROA: 13.5%
ROE: 33.6%
Debt/Equity: 0.58
Current Ratio: 1.10
Gross margin: 68.1%
Operating margin: 26.2%
Net margin: 21.5%
Dividend/share: $5.2
Div. yield: 1.94%
Growth Estimates
Revenue
CAGR: 8.6%FY+1$101.12(B)
FY+2(+7.6%)$108.77(B)
FY+3(+9.4%)$118.94(B)
FY+4(+9.0%)$129.61(B)
FY+5(+8.4%)$140.46(B)
Net Income
CAGR: 16.8%FY+1$26.98(B)
FY+2(+11.1%)$29.98(B)
FY+3(+24.3%)$37.28(B)
FY+4(+17.7%)$43.88(B)
FY+5(+14.4%)$50.21(B)
EPS
CAGR: 16.9%FY+1$11.05
FY+2(+11.4%)$12.31
FY+3(+24.6%)$15.34
FY+4(+17.7%)$18.05
FY+5(+14.3%)$20.64
FCF per share
CAGR: 9.8%FY+1$9.98
FY+2(+12.8%)$11.26
FY+3(+10.5%)$12.44
FY+4(+12.5%)$13.99
FY+5(+3.8%)$14.53
